United Therapeutics Says Informed by Medtronics that FDA issued Response Letter Indicating PMA is Not Approvable; UTHR Expects FDA Action in 2016 Regarding NDA Seeking FDA Approval of New Labeling for Remodulin
March 24, 2016 at 06:19 AM EDT
On March 15, 2016, United Therapeutics Corporation (NASDAQ: UTHR) was informed by Medtronic Inc. (NYSE: MDT) that the U.S. Food and Drug ...